Palbociclib/Ruxolitinib Combo Shows Preclinical Promise in Myelofibrosis
OncLive,
Palbociclib plus ruxolitinib led to normalized blood leukocyte counts, reduced splenomegaly, and significantly improved bone…
Palbociclib plus ruxolitinib led to normalized blood leukocyte counts, reduced splenomegaly, and significantly improved bone…
The breast cancer drug palbociclib may be able to treat myelofibrosis either alone or in combination with ruxolitinib.
【字体: 大 中 小 】 时间:2021年08月16日 来源:University of Virginia Health System 编辑推荐: 一项新的研究表明,一种用于治疗某些晚期乳腺癌的药物可能为一种称为骨髓纤维化的致命血癌提供了一种新的治疗选择…
A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis.
A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis.
A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis.
A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis.
A drug used to treat certain advanced breast cancers may offer a new treatment option for a deadly blood cancer known as…
A drug used to treat certain advanced breast cancers may offer a new treatment option for a deadly blood cancer known as…
Credit: CC0 Public Domain A drug used to treat certain advanced breast cancers may offer a new treatment option for a deadly…
A drug used to treat certain advanced breast cancers may offer a new treatment option for a deadly blood cancer known as…